These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21434838)

  • 21. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Physiological role of lysophosphatidic acid and its relevancephysiological role of lysophosphatidic acid and its relevance to diseases].
    Shimizu Y; Tokumura A
    Seikagaku; 2011 Jun; 83(6):506-17. PubMed ID: 21800681
    [No Abstract]   [Full Text] [Related]  

  • 23. Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3.
    Chiang CL; Chen SS; Lee SJ; Tsao KC; Chu PL; Wen CH; Hwang SM; Yao CL; Lee H
    Stem Cells; 2011 Nov; 29(11):1763-73. PubMed ID: 21915944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidic acid increases the production of pivotal mediators of decidualization and vascularization in the rat uterus.
    Beltrame JS; Sordelli MS; Cella M; Perez Martinez S; Franchi AM; Ribeiro ML
    Placenta; 2013 Sep; 34(9):751-6. PubMed ID: 23790320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.
    Swaney JS; Chapman C; Correa LD; Stebbins KJ; Broadhead AR; Bain G; Santini AM; Darlington J; King CD; Baccei CS; Lee C; Parr TA; Roppe JR; Seiders TJ; Ziff J; Prasit P; Hutchinson JH; Evans JF; Lorrain DS
    J Pharmacol Exp Ther; 2011 Mar; 336(3):693-700. PubMed ID: 21159750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis.
    Zhao J; Wei J; Weathington N; Jacko AM; Huang H; Tsung A; Zhao Y
    Transl Res; 2015 Jul; 166(1):80-8. PubMed ID: 25701366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
    Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
    Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma.
    Sokolov E; Eheim AL; Ahrens WA; Walling TL; Swet JH; McMillan MT; Simo KA; Thompson KJ; Sindram D; McKillop IH
    J Surg Res; 2013 Mar; 180(1):104-13. PubMed ID: 23182454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
    Ohashi T; Yamamoto T
    Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblasts.
    Qian Y; Hamilton M; Sidduri A; Gabriel S; Ren Y; Peng R; Kondru R; Narayanan A; Truitt T; Hamid R; Chen Y; Zhang L; Fretland AJ; Sanchez RA; Chang KC; Lucas M; Schoenfeld RC; Laine D; Fuentes ME; Stevenson CS; Budd DC
    J Med Chem; 2012 Sep; 55(17):7920-39. PubMed ID: 22894757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse effects of LPA receptors on cell motile activities of cancer cells.
    Tsujiuchi T; Hirane M; Dong Y; Fukushima N
    J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innovative antifibrotic therapies in systemic sclerosis.
    Beyer C; Distler O; Distler JH
    Curr Opin Rheumatol; 2012 May; 24(3):274-80. PubMed ID: 22450392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
    Tager AM; LaCamera P; Shea BS; Campanella GS; Selman M; Zhao Z; Polosukhin V; Wain J; Karimi-Shah BA; Kim ND; Hart WK; Pardo A; Blackwell TS; Xu Y; Chun J; Luster AD
    Nat Med; 2008 Jan; 14(1):45-54. PubMed ID: 18066075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
    Miyabe Y; Miyabe C; Iwai Y; Takayasu A; Fukuda S; Yokoyama W; Nagai J; Jona M; Tokuhara Y; Ohkawa R; Albers HM; Ovaa H; Aoki J; Chun J; Yatomi Y; Ueda H; Miyasaka M; Miyasaka N; Nanki T
    Arthritis Rheum; 2013 Aug; 65(8):2037-47. PubMed ID: 23666827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.
    Tabata K; Baba K; Shiraishi A; Ito M; Fujita N
    Biochem Biophys Res Commun; 2007 Nov; 363(3):861-6. PubMed ID: 17905198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
    Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
    Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
    Kim J; Keys JR; Eckhart AD
    Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lysophosphatidic acid: a "bioactive" phospholipid].
    Saulnier-Blache JS
    Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.